Sampling of Malaria Vaccines in Human Testing
GROUPSVACCINE/STATUS
GlaxoSmithKline Biologicals (Rixensart, Belgium) Protein vaccines; the most advanced is in phase II clinical trials in children in Africa
Queensland Institute of Medical Research (Brisbane, Australia);
Cooperative Research Centre for Vaccine Technology (Brisbane, Australia)
Protein vaccine; phase I trials
University of Oxford (Oxford, England); Oxxon Pharmaccines (Oxford, England); Impfstoffwerk Dessau-Tornau (Rosslau and Dessau, Germany)DNA vaccine; phase II clinical trials in Africa
Walter Reed Army Institute of Research (Forest Glen, MD)Protein vaccines; the most advanced is in phase II trials in Africa